Nuvation Bio, Inc. (NUVB)
6.76
-0.17
(-2.45%)
USD |
NYSE |
Aug 24, 16:00
6.85
+0.09
(+1.33%)
Pre-Market: 09:10
Nuvation Bio EPS Diluted (Quarterly) : -0.1802 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1802 |
| March 31, 2026 | 0.0143 |
| December 31, 2025 | -0.1063 |
| September 30, 2025 | -0.163 |
| June 30, 2025 | -0.1732 |
| March 31, 2025 | -0.1572 |
| December 31, 2024 | -0.1468 |
| September 30, 2024 | -0.1506 |
| June 30, 2024 | -1.890 |
| March 31, 2024 | -0.0675 |
| December 31, 2023 | -0.063 |
| September 30, 2023 | -0.0898 |
| June 30, 2023 | -0.0943 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.0993 |
| December 31, 2022 | -0.0954 |
| September 30, 2022 | -0.1246 |
| June 30, 2022 | -0.1609 |
| March 31, 2022 | -0.0998 |
| December 31, 2021 | -0.1196 |
| September 30, 2021 | -0.1061 |
| June 30, 2021 | -0.0948 |
| March 31, 2021 | -0.1202 |
| December 31, 2020 | -0.1074 |
| September 30, 2020 | -0.0955 |
| June 30, 2020 | -0.4659 |
| March 31, 2020 | -0.4739 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.620 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
| Pfizer Inc. | -0.0435 |
| EyePoint, Inc. | -1.092 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -62.84M |
| Revenue (Quarterly) | 31.69M |
| Total Expenses (Quarterly) | 94.53M |
| Enterprise Value | 2.120B |
| Gross Profit Margin (Quarterly) | 68.42% |
| Profit Margin (Quarterly) | -198.3% |
| Earnings Yield | -6.44% |
| Normalized Earnings Yield | -6.219 |